Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
about
Treatment of the genitourinary syndrome of menopause.Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women.Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study.Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy.Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.Oestrogens and overactive bladder.Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.Assessment of vaginal atrophy: a review.Monurelle Biogel(®) vaginal gel in the treatment of vaginal dryness in postmenopausal women.Vaginal oestrogen for overactive bladder in post-menopausal women.Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014.Rectovaginal fistula: Twenty years of rectovaginal repair.Prevalence and correlates of vaginal estrogenization in postmenopausal women in the United States.Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.Progress and prospects in treating postmenopausal vaginal atrophy.Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.Oestrogen receptor alpha expression in neovaginal tissue of women following modified Abbé-McIndoe technique and in premenopausal women.Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.The relationship between urogenital symptoms and climacteric complaints.CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) survey in South Africa.New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).Isoflavones derived from Glycine max (L.) Merr. in the treatment of vaginal atrophy: A new frontier.Study on Prevalence and Severity of Urogenital Complaints in Postmenopausal Women at a Tertiary Care Hospital
P2860
Q35772318-D514C383-366C-4BF9-A1BC-174E0014EA87Q36049247-63EC9A1A-E048-4142-B1F8-1C7B43B018CBQ36371627-201ECE10-14B0-4E1A-B68D-F339FEB35B07Q37552246-2467E059-EAC5-4F38-A0A1-5ACDA808CF9AQ37644620-6C7587F7-5734-4983-AE06-9DE13C460BC6Q37992713-F355BD29-BAC4-430E-BD1B-840A44EDEAC2Q38106748-AC62242C-A178-417D-96D7-BF2D2E742274Q38121156-C9FE3B72-C684-4623-876D-2BC4C57EABAFQ38122627-5A7BC8FB-D690-444E-B862-F557CF9D8BA8Q38178431-EB102EA0-9CD4-4A34-8818-0AD53D0FDCF2Q38232359-DD13C76B-42C6-4CB9-9058-A0E072A2902FQ38374840-DE96479B-CEA6-4E83-A2E5-09007291DAA1Q38525693-2259E511-CA8B-474D-9433-A0DA9F64C15AQ38731395-210D573E-CD67-4B78-9EBC-8D7E9DEEEBDBQ38880206-B9B744FB-024B-463D-B148-4AC3B19BC617Q39145391-FEB2FC9F-FDC7-4717-9599-060382EC2762Q39191397-76FFA1E1-581D-45CC-ABF7-E8B001665A26Q39827992-ACAB0C4D-18DA-479D-A24D-3F83BE09BAB4Q40383995-9FAA0FD7-E314-4830-99D2-7E1A0B75A5F7Q42471076-6CF89BCC-5956-490A-BBB5-AFC05A8FF501Q43772040-CAF25DE3-4D55-4F08-93B2-84B5FFB206D6Q43969015-A1D4BE35-E6DD-4BA3-A25C-F067E2DA0F24Q44961483-AE7460FA-B1FE-4F0D-9E79-4C52A20F1BE2Q46728259-0961BB22-4D4A-475F-AEB8-8579EAA708BFQ47549545-57F57796-4949-48F6-91AF-72804902C3AAQ48671400-627D5D42-868D-42A5-9984-F3A842DFDD42Q49822445-4E1E9C8F-4E9C-4111-B9C3-A78C6D518F71Q49849015-C5CF3934-1593-4116-A58D-F43E2316AEF5Q57193022-2F93E35A-229B-4E76-9847-15B8FEA778A6
P2860
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@en
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@nl
type
label
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@en
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@nl
prefLabel
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@en
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@nl
P1433
P1476
Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
@en
P2093
David F Archer
P304
P356
10.1097/GME.0B013E3181A95581
P407
P577
2010-01-01T00:00:00Z